<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d0">
    <sentence id="DDI-DrugBank.d0.s0" text="The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate.">
        <entity id="DDI-DrugBank.d0.s0.e0" charOffset="26-32"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d0.s0.e1" charOffset="38-48"
            type="drug" text="Acamprosate"/>
        <entity id="DDI-DrugBank.d0.s0.e2" charOffset="97-103"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d0.s0.e3" charOffset="108-118"
            type="drug" text="acamprosate"/>
    </sentence>
    <sentence id="DDI-DrugBank.d0.s1" text="Pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate.">
        <entity id="DDI-DrugBank.d0.s1.e0" charOffset="56-65"
            type="drug" text="disulfiram"/>
        <entity id="DDI-DrugBank.d0.s1.e1" charOffset="70-77"
            type="drug" text="diazepam"/>
        <entity id="DDI-DrugBank.d0.s1.e2" charOffset="119-129"
            type="drug" text="acamprosate"/>
    </sentence>
    <sentence id="DDI-DrugBank.d0.s2" text="Co-administration of naltrexone with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.">
        <entity id="DDI-DrugBank.d0.s2.e0" charOffset="21-30"
            type="drug" text="naltrexone"/>
        <entity id="DDI-DrugBank.d0.s2.e1" charOffset="37-47"
            type="drug" text="Acamprosate"/>
        <entity id="DDI-DrugBank.d0.s2.e2" charOffset="114-124"
            type="drug" text="acamprosate"/>
        <ddi id="DDI-DrugBank.d0.s2.d0" e1="DDI-DrugBank.d0.s2.e0"
            e2="DDI-DrugBank.d0.s2.e1" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d0.s3" text="No adjustment of dosage is recommended in such patients."/>
    <sentence id="DDI-DrugBank.d0.s4" text="The pharmacokinetics of naltrexone and its major metabolite 6-beta-naltrexol were unaffected following co-administration with Acamprosate.">
        <entity id="DDI-DrugBank.d0.s4.e0" charOffset="24-33"
            type="drug" text="naltrexone"/>
        <entity id="DDI-DrugBank.d0.s4.e1" charOffset="60-75"
            type="drug_n" text="6-beta-naltrexol"/>
        <entity id="DDI-DrugBank.d0.s4.e2" charOffset="126-136"
            type="drug" text="Acamprosate"/>
    </sentence>
    <sentence id="DDI-DrugBank.d0.s5" text="Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.">
        <entity id="DDI-DrugBank.d0.s5.e0" charOffset="93-103"
            type="drug" text="Acamprosate"/>
        <entity id="DDI-DrugBank.d0.s5.e1" charOffset="124-134"
            type="group" text="anxiolytics"/>
        <entity id="DDI-DrugBank.d0.s5.e2" charOffset="137-145"
            type="group" text="hypnotics"/>
        <entity id="DDI-DrugBank.d0.s5.e3" charOffset="151-159"
            type="group" text="sedatives"/>
        <entity id="DDI-DrugBank.d0.s5.e4" charOffset="172-186"
            type="group" text="benzodiazepines"/>
        <entity id="DDI-DrugBank.d0.s5.e5" charOffset="193-213"
            type="group" text="non-opioid analgesics"/>
    </sentence>
    <sentence id="DDI-DrugBank.d0.s6" text="Patients taking Acamprosate concomitantly with antidepressants more commonly reported both weight gain and weight loss, compared with patients taking either medication alone.">
        <entity id="DDI-DrugBank.d0.s6.e0" charOffset="16-26"
            type="drug" text="Acamprosate"/>
        <entity id="DDI-DrugBank.d0.s6.e1" charOffset="47-61"
            type="group" text="antidepressants"/>
        <ddi id="DDI-DrugBank.d0.s6.d0" e1="DDI-DrugBank.d0.s6.e0"
            e2="DDI-DrugBank.d0.s6.e1" type="effect"/>
    </sentence>
</document>
